Condition

Anesthesia Induction

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions6

Lead sponsors shown3

Clinical trials

3 shown

Oxygenation Procedure for Obese Patients During Intubation in the Operating RoomNCT06914401 · 2025-06-19

COMPLETED

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine PretreatmentNCT05631028 · 2022-12-01

COMPLETED

High-flow Nasal Oxygenation in Obese Patients During ApneaNCT03195504 · 2017-08-10

COMPLETED

Common interventions

CON (control)DEVICE1 DexmedetomidineDRUG1 HFNCDEVICE1 NIV (Non Invasive Ventilation)PROCEDURE1 NIV (Non Invasive Ventilation) and HFNO (High Flow Nasal Oxygen)PROCEDURE1 Remimazolam tosilateDRUG1

Leading sponsors

Clinique Pasteur 1 Shiyou Wei 1 University Health Network, Toronto 1

Trial status mix

COMPLETED3

Phase mix

NA3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.